Skip to main content
Journal cover image

Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF.

Publication ,  Journal Article
Thomas, M; Khariton, Y; Fonarow, GC; Arnold, SV; Hill, L; Nassif, ME; Sharma, PP; Butler, J; Thomas, L; Duffy, CI; DeVore, AD; Hernandez, A ...
Published in: JACC Heart Fail
July 2019

OBJECTIVES: The aim of this study was to use a multicenter, observational outpatient registry of patients with heart failure with reduced ejection fraction (HFrEF) to describe the association between changes in patients' medications with changes in health status. BACKGROUND: Alleviating symptoms and improving function and quality of life for patients with HFrEF are primary treatment goals and potential indicators of quality. Whether titrating medications in routine clinical care improves patients' health status is unknown. METHODS: The association of any change in HFrEF medications with 3-month change in health status, as measured using the 12-item Kansas City Cardiomyopathy Questionnaire Overall Summary Scale, was determined in unadjusted and multivariate-adjusted (25 clinical characteristics, baseline health status) models using hierarchical linear regression. RESULTS: Among 3,313 outpatients with HFrEF from 140 centers, 21.9% had medication changes. Three months later, 23.7% and 46.4% had clinically meaningfully worse (≥5-point decrease) and improved (≥5-point increase) Kansas City Cardiomyopathy Questionnaire Overall Summary Scale scores. The 3-month median change in Kansas City Cardiomyopathy Questionnaire Overall Summary Scale score for patients whose HFrEF medications were changed was significantly larger (7.3 points; interquartile range: -3.1 to 20.8 points) than in patients whose medications were not changed (3.1 points; interquartile range: -4.7 to 12.5 points) (adjusted difference 3.0 points; 95% confidence interval: 1.4 to 4.6 points; p < 0.001). Among patients whose medications were adjusted, 26% had very large clinical improvement (≥20 points) compared with 14% whose regimens were not changed. CONCLUSIONS: In routine care of patients with HFrEF, changes in HFrEF medications were associated with significant improvements in patients' health status, suggesting that health status-based performance measures can quantify the benefits of titrating medicines in patients with HFrEF.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JACC Heart Fail

DOI

EISSN

2213-1787

Publication Date

July 2019

Volume

7

Issue

7

Start / End Page

615 / 625

Location

United States

Related Subject Headings

  • Registries
  • Quality of Life
  • Neprilysin
  • Mineralocorticoid Receptor Antagonists
  • Middle Aged
  • Male
  • Humans
  • Heart Failure
  • Health Status
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thomas, M., Khariton, Y., Fonarow, G. C., Arnold, S. V., Hill, L., Nassif, M. E., … Spertus, J. A. (2019). Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF. JACC Heart Fail, 7(7), 615–625. https://doi.org/10.1016/j.jchf.2019.03.020
Thomas, Merrill, Yevgeniy Khariton, Gregg C. Fonarow, Suzanne V. Arnold, Larry Hill, Michael E. Nassif, Puza P. Sharma, et al. “Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF.JACC Heart Fail 7, no. 7 (July 2019): 615–25. https://doi.org/10.1016/j.jchf.2019.03.020.
Thomas M, Khariton Y, Fonarow GC, Arnold SV, Hill L, Nassif ME, et al. Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF. JACC Heart Fail. 2019 Jul;7(7):615–25.
Thomas, Merrill, et al. “Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF.JACC Heart Fail, vol. 7, no. 7, July 2019, pp. 615–25. Pubmed, doi:10.1016/j.jchf.2019.03.020.
Thomas M, Khariton Y, Fonarow GC, Arnold SV, Hill L, Nassif ME, Sharma PP, Butler J, Thomas L, Duffy CI, DeVore AD, Hernandez A, Albert NM, Patterson JH, Williams FB, McCague K, Spertus JA. Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF. JACC Heart Fail. 2019 Jul;7(7):615–625.
Journal cover image

Published In

JACC Heart Fail

DOI

EISSN

2213-1787

Publication Date

July 2019

Volume

7

Issue

7

Start / End Page

615 / 625

Location

United States

Related Subject Headings

  • Registries
  • Quality of Life
  • Neprilysin
  • Mineralocorticoid Receptor Antagonists
  • Middle Aged
  • Male
  • Humans
  • Heart Failure
  • Health Status
  • Female